Sofinnova Partners SAS, 10% Owner at Omthera Pharmaceuticals, Inc. (OMTH), bought 7,159,513 shares at $8.00 ($10.1M) on 2013-04-16, disclosed to the SEC on 2013-04-18.
Open-market purchase of $10.1M OMTH by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 5,745,044 | $0 | 0.0% |
| 2 | $0.01 | 156,250 | $2K | 0.0% |
| 3 | $8.00 | 625,000 | $5.0M | 49.7% |
| 4 | $8.00 | 633,219 | $5.1M | 50.3% |
| Total | $1.41 avg | 7,159,513 | $10.1M | 100% |
| Filing → |
| HOOK | SELL | 2021-03-31 | $963K | — | Filing → |
| HOOK | SELL | 2021-03-29 | $749K | — | Filing → |
| HOOK | SELL | 2021-03-26 | $722K | — | Filing → |